341 Phase I clinical pharmacokinetics, safety and tolerability of simotinib in advanced NSCLC patients with EGFR mutation. (September 2015) - Han, X.; Li, N.; Hu, X.; Song, Y.; Zhang, Y.; Shi, Y.